ASX:SXE
ASX:SXEConstruction

ASX Penny Stocks To Watch In December 2025

As the Australian market approaches the end of 2025, it seems to be winding down for the holiday season with a slight dip, largely due to profit-taking and early closures. Despite this quiet period, investors continue to seek opportunities in niche areas like penny stocks, which remain relevant despite their somewhat outdated name. These stocks often represent smaller or newer companies that can offer significant growth potential when supported by strong financial foundations.
ASX:IPX
ASX:IPXMetals and Mining

Is IperionX (ASX:IPX) Using Navy Prototypes To Prove A Scalable Titanium Advantage?

IperionX Limited previously announced that Carver Pump Company placed an initial purchase order for prototype titanium components to accelerate U.S. Navy ship pump production, using IperionX’s low-cost titanium powder and Virginia manufacturing facility to replace long-lead-time cast parts. This move from planning to prototyping highlights how IperionX’s integrated titanium powder production and advanced manufacturing could help ease critical naval supply chain bottlenecks. With this project...
ASX:SVL
ASX:SVLMetals and Mining

Silver Mines (ASX:SVL): Valuation Check After Court-Ordered Delays to the Bowdens Silver Project

Silver Mines (ASX:SVL) is back in the spotlight after fresh delays to its Bowdens Silver Project, with the NSW Court of Appeal voiding prior approval and forcing new ecological surveys under updated biodiversity rules. See our latest analysis for Silver Mines. Despite the latest court setback, Silver Mines has delivered a powerful year to date, with a 143.59% share price return and a 137.5% one year total shareholder return. However, momentum has cooled in recent weeks as investors reassess...
ASX:MIN
ASX:MINMetals and Mining

Mineral Resources (ASX:MIN): Rethinking Valuation After Lithium Tailwinds and Onslow Iron Milestones

Mineral Resources (ASX:MIN) has jumped back onto investors radar after lithium prices spiked on Chinese supply disruptions, just as its Onslow Iron project hit nameplate capacity and delivered record quarterly shipments. See our latest analysis for Mineral Resources. Those lithium tailwinds and Onslow Iron milestones help explain why Mineral Resources has a 30 day share price return of 17.7 percent and a 1 year total shareholder return of 64.65 percent. Even though its 3 year total...
ASX:AYA
ASX:AYAHealthcare Services

Artrya (ASX:AYA) Secures Cone Health In Five-Year SaaS Deal Is Its U.S. Beachhead Emerging?

Artrya Limited recently announced a five-year SaaS agreement with U.S. healthcare provider Cone Health to roll out its Salix Coronary Anatomy and Plaque AI imaging modules across the health system’s network, securing its third commercial customer in the United States. This latest deal completes the conversion of all three of Artrya’s U.S. foundation partners, signalling growing clinical adoption and a deeper foothold in the competitive American cardiac imaging market. We’ll now examine how...
ASX:EOS
ASX:EOSAerospace & Defense

Reassessing Electro Optic Systems (ASX:EOS) Valuation After Landmark South Korea and US Defense Contracts

EOS stock jumps on landmark defense contracts Electro Optic Systems Holdings (ASX:EOS) is back on investor radars after securing an $80 million laser weapon deal with South Korea and a $22 million US Army contract, sharply improving revenue visibility. See our latest analysis for Electro Optic Systems Holdings. Those December defense wins cap an extraordinary run, with the share price delivering a year to date return of around 609 percent and a 1 year total shareholder return of about 677...
ASX:WDS
ASX:WDSOil and Gas

Woodside Energy Group (ASX:WDS): Revisiting Valuation After Recent Share Price Pullback

Latest move in Woodside Energy Group shares Woodside Energy Group (ASX:WDS) has slipped about 8% over the past month, even though the stock is roughly flat over the past 3 months and modestly higher over the past year. See our latest analysis for Woodside Energy Group. That recent 1 month share price return of about negative 8% stands in contrast to a mildly positive 1 year total shareholder return. This suggests momentum has cooled as investors reassess growth prospects and near term...
ASX:EOL
ASX:EOLSoftware

ASX Growth Stocks Insiders Are Betting On

As the Australian market approaches the holiday season, it's experiencing a slight dip, likely due to profit-taking and early closures, while Wall Street indices near record highs. In this environment of cautious optimism, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
ASX:DJW
ASX:DJWCapital Markets

3 Undiscovered Gems In Australia To Enhance Your Investment Portfolio

As the Australian market edges towards the holiday season with a slight dip, largely due to profit-taking and early closures, investors are keeping an eye on small-cap stocks amidst broader market fluctuations. In this environment, identifying promising yet overlooked companies can be key to enhancing your investment portfolio, especially as these gems may offer unique opportunities in times of economic shifts.
ASX:BKI
ASX:BKICapital Markets

ASX Penny Stock Highlights: BKI Investment And Two Other Standout Picks

As the Australian market winds down for the holiday season, with a slight dip of 0.2% attributed to profit-taking before the break, investors are keeping an eye on precious metals and commodities. For those willing to explore beyond established names, penny stocks—despite their vintage moniker—remain a relevant investment area that can offer unique opportunities. This article highlights three standout penny stocks on the ASX that demonstrate financial strength and potential for long-term...
ASX:WES
ASX:WESMultiline Retail

Assessing Wesfarmers (ASX:WES) Valuation After Infinity Pharmacy Group’s Priceline Administration News

Wesfarmers (ASX:WES) is back in focus after more than 50 Priceline pharmacies tied to Infinity Pharmacy Group went into administration, which has sharpened attention on execution risks in its expanding health and pharmacy division. See our latest analysis for Wesfarmers. The latest concerns around Infinity Pharmacy Group land at a time when Wesfarmers’ A$81.56 share price is already consolidating after a weaker 90 day share price return, even as its one year total shareholder return of 18.95...
ASX:4DX
ASX:4DXHealthcare Services

Assessing 4DMedical (ASX:4DX) Valuation After Cleveland Clinic CT:VQ Deal and Rapid US Hospital Adoption

4DMedical (ASX:4DX) just signed a commercial deal with the Cleveland Clinic for its CT:VQ imaging platform, and investors are taking notice as deployments accelerate across leading U.S. academic hospitals. See our latest analysis for 4DMedical. The market clearly sees this Cleveland Clinic deal as validation, with a 30 day share price return of roughly 149 percent and a one year total shareholder return above 760 percent. This points to strong, momentum driven optimism about 4DMedical’s long...